Inspire Medical Systems (INSP)
Uses hypoglossal-nerve stimulation to treat obstructive sleep apnea.
$71.87
After hours+0.62 (+0.87%)
At close$71.25(−5.90%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 153 | 193 | 164 | 196 | 203 | 240 | 201 | 217 | 225 | 269 | 205 | 201 |
| Cost of revenue | 24 | 28 | 25 | 30 | 32 | 36 | 31 | 35 | 32 | 36 | 28 | 29 |
| Gross profit | 129 | 164 | 139 | 166 | 171 | 204 | 171 | 182 | 193 | 233 | 177 | 171 |
| 142 | 155 | 154 | 161 | 156 | 172 | 172 | 186 | 183 | 187 | 178 | 172 | |
| Research & development | 29 | 31 | 29 | 29 | 26 | 30 | 28 | 26 | 24 | 25 | 26 | 25 |
| 113 | 124 | 126 | 132 | 130 | 142 | 144 | 160 | 159 | 162 | 152 | 147 | |
| Selling & marketing | 0 | 0 | 26 | 23 | 23 | 23 | 21 | 25 | 36 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 100 | 109 | 107 | 119 | 123 | 135 | 122 | 0 | 0 | 0 |
| Operating income | −13 | 9 | −15 | 5 | 14 | 32 | −1 | −3 | 10 | 46 | −1 | −1 |
| 5 | 6 | 6 | 6 | 6 | 5 | 6 | 1 | 4 | 4 | 4 | 4 | |
| Interest income | 5 | 6 | 6 | 6 | 6 | 6 | 5 | 4 | 4 | 4 | 4 | 4 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | −6 | −6 | −6 | −6 | −22 | −6 | −1 | −4 | −4 | −4 | 0 |
| Income before tax | −8 | 15 | −9 | 11 | 20 | 37 | 4 | −2 | 14 | 50 | 2 | 3 |
| Income tax expense | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 4 | −86 | 14 | 3 |
| Net income from continuing operations | −9 | 15 | −10 | 10 | 18 | 35 | 3 | −4 | 10 | 136 | −11 | 0 |
| Net income | −9 | 15 | −10 | 10 | 18 | 35 | 3 | −4 | 10 | 136 | −11 | 0 |
| EPS, basic | −$0.29 | $0.50 | −$0.34 | $0.33 | $0.62 | $1.18 | $0.10 | −$0.12 | $0.34 | $4.70 | −$0.39 | $0.01 |
| EPS, diluted | −$0.29 | $0.49 | −$0.34 | $0.32 | $0.60 | $1.15 | $0.10 | −$0.12 | $0.34 | $4.66 | −$0.39 | $0.01 |
| Weighted average shares, basic | 29 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 | 29 |
| Weighted average shares, diluted | 29 | 30 | 30 | 30 | 31 | 31 | 30 | 30 | 30 | 29 | 29 | 29 |
| EBITDA | −13 | 16 | −9 | 12 | 22 | 57 | 7 | 1 | 17 | 54 | 8 | 4 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 5 |
| EBIT | −13 | 15 | −9 | 11 | 20 | 54 | 4 | −2 | 14 | 50 | 2 | −1 |